TODAY'S HEADLINES

FDA approves drug for rare liver disease

FDA recently granted accelerated approval for this drug to treat primary biliary cholangitis. Read more

FDA warns about popular diabetes drugs

In alarming news for diabetic patients taking canagliflozin (Invokana, Invokamet) medications, FDA is warning that interim safety results from an ongoing clinical trial found an increase in foot and leg amputations with the drugs. Read more

CONTINUING PHARMACY EDUCATION

The rundown: Management of acute and chronic diarrhea

This month's CE activity, "The rundown: Management of acute and chronic diarrhea," is open for pharmacists and pharmacy technicians.
The goal of this activity is to review the various risk factors, etiologies, and treatments of diarrhea as well as the pharmacist's role in its management.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Top 5 facts about cancer drug costs

Global spending on cancer drugs is rising at an alarming rate. Here are the top five facts to know about oncology drug spending in a revealing new report. Read more

June 15, 2016

Related Articles

New hypertension drug gets FDA approval

FDA: Diabetes drugs don't need death warning